Precision BioSciences, Inc.

Some of the best links we picked up around the internet

ARCUS Gene Editor Shows Promise Against Hepatitis...

Sep. 17, 2025

Precision BioSciences presented encouraging early clinical results from its PBGENE-HBV programme at the 6th International Coalition to Eliminate HBV...

CMN Weekly (12 September 2025) - Your Weekly...

CMN Weekly

Sep. 12, 2025

Some of the best links we picked up around the internet

CMN Weekly (8 August 2025) - Your Weekly CRISPR...

CMN Weekly

Aug. 8, 2025

Some of the best links we picked up around the internet

CMN Weekly (1 August 2025) - Your Weekly CRISPR...

CMN Weekly

Aug. 1, 2025

Some of the best links we picked up around the internet

CMN Weekly (25 July 2025) - Your Weekly CRISPR...

CMN Weekly

Jul. 25, 2025

Some of the best links we picked up around the internet

CMN Weekly (18 July 2025) - Your Weekly CRISPR...

CMN Weekly

Jul. 18, 2025

Some of the best links we picked up around the internet

CMN Weekly (11 July 2025) - Your Weekly CRISPR...

CMN Weekly

Jul. 11, 2025

Some of the best links we picked up around the internet

Precision BioSciences, Inc.

Chronic Hepatitis B, HBV, (NCT06680232)
Sponsors:
Precision BioSciences, Inc.

IND Enabling

Phase I

Phase II

Phase III

B-Cell Non-Hodgkin Lymphoma, NHL, (NCT04649112)
Sponsors:
Precision BioSciences Inc.

IND Enabling

Phase I

Phase II

Phase III

B-cell Acute Lymphoblastic Leukaemia, B-ALL, (NCT03666000)
Sponsors:
Imugene Limited

IND Enabling

Phase I

Phase II

Phase III

Relapsed or Refractory Multiple Myeloma, MM, (NCT04171843)
Sponsors:
Precision BioSciences, Inc.

IND Enabling

Phase I

Phase II

Phase III

Relapsed or Refractory Lymphoma and Leukaemia, (NCT04030195)
Sponsors:
Precision BioSciences, Inc.

IND Enabling

Phase I

Phase II

Phase III